Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

New Drug Application News Monitoring

Get by Email • RSS

Published on May 30, 2025

May in Review: Updates on the Psychiatric Treatment Pipeline

Take a look at this month’s developments in the psychiatric treatment pipeline. We compiled a recap of the latest news here, just in case you missed any of the updates. FDA Filing Fee Waiver for New Drug Application of NRX-100 for Suicidal Depression NRx …

Source: Psychiatric Times - New Jersey - Pending
Published on May 30, 2025

Auron doses first subject in AUTX-703 trial for haematologic malignancies

Auron Therapeutics has dosed the first subject in the multicentre Phase I trial of the orally available lysine acetyltransferase 2A (KAT2A) and lysine acetyltransferase 2B (KAT2B) degrader, AUTX-703, targeting individuals with advanced haematologic …

Source: Clinical Trials Arena - Pending
Published on May 30, 2025

Phase 3 Trial Shows Promise for Oral Antibiotic Tebipenem pivoxil hydrobromide in Treating Complicated UTIs

Topline results from the phase 3 PIVOT-PO trial have revealed that tebipenem pivoxil hydrobromide (HBr), an investigational oral carbapenem antibiotic, was evaluated in 1,690 adults with complicated urinary tract infections (cUTIs) or acute pyelonephritis. …

Source: Medical Dialogues - Indeterminate
Published on May 30, 2025

URGN Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against UroGen Pharma Ltd.

SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025. …

Distribution channels: Consumer Goods, Law ...
Published on May 30, 2025

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against UroGen Pharma Ltd. (URGN)

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of all persons or entities who purchased …

Distribution channels: Consumer Goods, Law ...
Published on May 30, 2025

URGN Investors Have the Opportunity to Lead the UroGen Pharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In UroGen To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in UroGen between July …

Source: WFMZ - Pennsylvania - Neutral
Published on May 30, 2025

URGN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that UroGen Pharma Ltd. Investors with Substantial ...

SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, inclusive (the “Class Period”), …

Distribution channels: Consumer Goods, Law ...
Published on May 30, 2025

GSK & Spero Therapeutics announce PIVOT─PO phase III study for tebipenem HBr stopped early for efficacy following review ...

GSK plc and Spero Therapeutics announced that the pivotal phase III PIVOT-PO trial evaluating tebipenem HBr, an investigational oral treatment for complicated urinary tract infections (cUTIs), including pyelonephritis, will stop early for efficacy ( …

Source: Pharmabiz.com - Neutral
Published on May 30, 2025

Porton Advanced Announces Collaboration With TongEYE To Accelerate Development Of iPSC-RPEC Transplantation Therapy

Suzhou, China /PRNewswire/ - Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with TongEye Medical Technology ( …

Source: Outsourced Pharma - Pending
Published on May 30, 2025

Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic ...

Zanidatamab is the first and only dual HER2-targeted bispecific antibody approved for HER2+ biliary tract cancer in China; conditional approval based on the results of the HERIZON-BTC-01 clinical study $20 million milestone payment to be received from …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 30, 2025

Innovent Biologics doses first participant in phase 3 clinical study of picankibart

Innovent Biologics, Inc, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, …

Source: Pharmabiz.com - Neutral
Published on May 29, 2025

UroGen Pharma Ltd. Investors: Please contact the Portnoy Law Firm to recover your losses. July 28, 2025 Deadline to file ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 29, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises UroGen Pharma Ltd. ("UroGen " or the "Company") (NASDAQ: URGN) …

Distribution channels: Consumer Goods, Law ...
Published on May 29, 2025

Phase 3 trial for oral cUTI antibiotic stopped early for efficacy

Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral antibiotic for complicated urinary tract infections (cUTIs) was stopped early for efficacy. The PIVOT-PO trial was stopped after the …

Source: CIDRAP - Neutral
Published on May 29, 2025

Replacing Color Additives in Approved or Marketed Drug Products

Docket Number: FDA-2025-D-0507 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled “Replacing Color Additives …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on May 29, 2025

Remyelination in Multiple Sclerosis: Progress and Pipeline Updates

Over the years, remyelination in multiple sclerosis (MS) has been an emerging and intriguing topic that several in the field are still trying to crack. While therapeutics for MS have been largely successful in reducing relapses, there are no approved …

Source: NeurologyLive - Pending
Published on May 29, 2025

How Psychedelics Affected Nova Festival Survivors

Sometimes tragedy yields important information. A recent peer-reviewed study published in the Journal of Psychopharmacology examined the psychological impact of psychoactive substance use among the survivors of the October 7, 2023, terrorist attack and …

Source: Psychology Today - Neutral
Published on May 29, 2025

First Patient Imaged in Phase 3 AMPLIFY Trial for BCR of Prostate Cancer

The first patient has been imaged in the registrational phase 3 AMPLIFY (NCT06970847) trial of 64Cu-SAR-bisPSMA in patients with biochemical recurrence (BCR) of prostate cancer.1 64Cu-SAR-bisPSMA is a novel diagnostic that has demonstrated superiority …

Source: Targeted Oncology - Pending
Published on May 29, 2025

Encouraging SRC Findings on Ph I/II Skin Cancer Trial

The election of the following directors for the ensuing year: Jennifer Chao, David Elsley, Dr. Timothy Garnett, Teri Loxam, Peter Pekos, Colin Stott, Dr. Guillermo Torre-Amione, and Chris Waddick. The appointment of BDO Canada LLP as auditors of the …

Source: Investing News Network - Neutral
Published on May 29, 2025

Dermatology Times May 2025 Recap

Clearances, Approvals, Updates, and Recommendations FDA Approves Sun Pharma's New LED BLU-U Device for AK Sun Pharma's innovative BLU-U device gains FDA approval, revolutionizing actinic keratosis treatment with advanced blue light therapy. FDA …

Source: Dermatology Times - Neutral

29 days 19:01:08

Featured Releases

Got News to Share? · Submit · See All

Published on June 2, 2025 - 11:28 GMT

In-Depth Analysis Of The Global Pharma And Biotech Crm Software Market: Key Drivers, Trends, And Forecast 2025-2034

The Business Research Company's Pharma And Biotech CRM Software Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:03 GMT

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

CORAL GABLES, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of William (Will) T. Andrews, MD, FACP as Chief Medical Officer. Dr. Andrews …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on June 2, 2025 - 11:00 GMT

NervGen Pharma Reports Positive Topline Data from the Chronic Cohort of its Phase 1b/2a Clinical Trial Evaluating NVG-...

Study met its primary endpoint by achieving statistical significance on one of its two pre-specified co-primary endpoints, demonstrating increased electrical connectivity between the brain and hand muscle in individuals with a cervical level spinal cord …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:00 GMT

SpyGlass Pharma Raises $75 Million Series D Funding to Advance Its Long-term Drug Delivery Platform for Glaucoma ...

Financing supports SpyGlass Pharma’s platform through the readout of two Phase III pivotal trials ALISO VIEJO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a privately held ophthalmic biotechnology company, today announced the closing of a $ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 2, 2025 - 11:00 GMT

Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory ...

--Completion of GLP toxicology studies associated with a $50 million payment to Recludix under the collaboration with Sanofi -- REX-8756 is a potent and selective oral STAT6 inhibitor that demonstrates complete pathway inhibition and is well tolerated in …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 12:00 GMT

Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference

CONSHOHOCKEN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the 46th Annual Global Goldman Sachs Health Care Conference on Wednesday, June 11, 2025 at 10:40 A.M. …

Distribution channels:
Published on June 2, 2025 - 11:00 GMT

Sanofi Exercises License Extension Option to Nurix’s STAT6 Program

STAT6 is a key transcription factor within the IL4/IL13 signaling pathways which act as drivers of inflammation in allergic conditions Nurix to receive a $15 million license extension fee from Sanofi under its 2019 collaboration agreement, bringing the …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 14:32 GMT

If you are a Long-Term Shareholder of DoubleVerify Holdings, Inc. (NYSE: DV); Maison Solutions, Inc. (NASDAQ: MSS); ...

PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- DoubleVerify Holdings, Inc. (NYSE: DV): If you have held DoubleVerify Holdings, Inc. (NYSE: DV) shares since prior to November 10, 2023, and would like to learn more about the investigation and your rights, …

Distribution channels: Business & Economy, Law ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 818,279,467 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 2, 2025 - 14:48 GMT

Rett Syndrome Drug Race Intensifies as Gene Therapies Challenge Trofinetide’s Market Reign | Competitive Intelligence

Rett syndrome care is evolving as DAYBUE leads the market and next-gen therapies like gene and neuroplasticity agents aim to redefine treatment standards AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Rett Syndrome Drug Race …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 14:45 GMT

Physician Collaborators Now Supporting Nurse Practitioners Practicing in 41 States

Leading healthcare collaboration network’s expansion brings collaborative physician services to practitioners across the United States. JERSEY CITY, NJ, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Physician Collaborators, a premier network …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 14:32 GMT

Race to Treat Spinocerebellar Ataxia Accelerates as First Commercial Therapy Nears FDA Nod | DataM Intelligence

The Spinocerebellar Ataxia pipeline is advancing fast as troriluzole nears FDA nod and rivals race with gene and stem cell therapies to seize market edge. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Race to Treat …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 14:23 GMT

New Wave of Therapies for Hidradenitis Suppurativa Targets Deeper Efficacy and Patient-Centered Innovation | CI Insights

The hidradenitis suppurativa market is evolving as developers target novel immune pathways and next-gen therapies for improved patient outcomes. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- New Wave of Therapies for Hidradenitis …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 14:15 GMT

GenBio CSO Addresses Protecting the Kidneys

Approximately 850 million people worldwide are estimated to have kidney disease ALISO VIEJO, CA, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Chronic kidney disease involves the gradual loss of the ability of the kidney to remove waste …

Distribution channels: Banking, Finance & Investment Industry, Conferences & Trade Fairs ...
Published on June 2, 2025 - 14:11 GMT

Healthcare Cybersecurity Market Surges as Global Health Systems Brace for Digital Threats | DataM Intelligence

Healthcare cybersecurity market is expected to reach a value of approximately US$ 82.9 billion by 2033, which is equivalent to an 18.5% CAGR between 2025-2033 AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The global healthcare …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 14:00 GMT

Parkview Dental Associates SC: Expands Services with Advanced Solutions for Dental Crowns, Bridges, and Emergency Care

Parkview Dental Associates SC expands its services, offering advanced solutions for dental crowns, bridges, and emergency care to enhance patient care. SUN PRAIRIE, WI, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Parkview Dental Associates …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 14:00 GMT

Invest-med Promotes Full-Body MRI Testing in Support of Men’s Health Month

Offered at its Calgary, Edmonton and Vancouver clinics, Full-Body MRI testing allows Canadian men to proactively make informed decisions about their health. CALGARY, AB, CANADA, June 2, 2025 /⁨EINPresswire.com⁩/ -- June marks Men’s Health Month in …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on June 2, 2025 - 14:00 GMT

Student Doctor Network Launches Prehealth Scholarship Fund Campaign to Empower Future Healthcare Leaders

HUNTINGTON BEACH, OH, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Student Doctor Network (SDN) is proud to announce the launch of its inaugural Prehealth Scholarship Fund Campaign, a bold initiative to raise $100,000 and support a …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 14:00 GMT

Trauma Therapist Rebrands Practice as Instar Healing to Offer Holistic, Personalized Care for Women

Jenn Hoffman, LCSW, rebrands her therapy practice as Instar Healing, expanding trauma therapy services in-person and virtually across Connecticut & New York. FARMINGTON, CT, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Clinically trained …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 14:00 GMT

PayToMe.co Joins NVIDIA Inception to Tackle $46B SMB Finance Problem With AI

NVIDIA Inception supports PayToMe.co’s mission to empower 400M SMBs with real-time payments, compliance automation, and global AI infrastructure. SAN FRANCISCO, CA, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- 🚀 PayToMe.co, an award-winning …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on June 2, 2025 - 13:58 GMT

Able2Change Recovery: Embracing Trauma-Informed Care for Addiction Treatment in Orange County

Able2Change Orange County Drug & Alcohol Rehab is a leading addiction and mental health treatment center in Orange County since 1999. SAN JUAN CAPISTRANO, CA, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Able2Change Orange County Drug …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 2, 2025 - 13:58 GMT

Able To Change Recovery: The Science and Success Behind Contingency Management Therapy

CM Therapy is a behavioral approach rooted in the science of positive reinforcement. SAN JUAN CAPISTRANO, CA, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Able To Change Mental Health & Depression Treatment Center, a leading provider of mental …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 2, 2025 - 13:51 GMT

New Documentary Highlights Advances in Headache Research and Offers Hope to Billions

The International Headache Society (IHS) is set to launch the documentary series Headed for the Future at the start of Migraine Awareness Month. LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The International Headache Society (IHS) is set …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 13:43 GMT

The Freedom Center Expands Access to Outpatient Addiction Treatment in Maryland

Through a range of outpatient care options, the center offers structured support for individuals managing substance use and co-occurring mental health disorders GAITHERSBURG, MD, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Freedom …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 2, 2025 - 13:40 GMT

Closed System Drug Transfer Devices Market Size, Trends, Share & Forecast 2025 | DataM Intelligence

The Global Closed System Transfer Devices (CSTD) Market is estimated to reach at a CAGR 11.7% during the forecast period (2025-2033). AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Global Closed System Drug Transfer Devices …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 13:05 GMT

Global Dysport Market Forecast 2025-2034: Analyzing Growth Drivers, Market Share, Segments, And Emerging Trends

The Business Research Company's Dysport Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- In the past few years, the Dysport market has …

Distribution channels: Business & Economy, Companies ...
Published on June 2, 2025 - 13:00 GMT

Buscar Company Acquires 70% Stake in Armorgenix

Buscar Company (OTCMKTS:CGLD) BEVERLY HILLS, CA, CA, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Buscar Company Acquires 70% Stake in Armorgenix, Bolstering Portfolio with Pharmaceutical Innovation and Positioning for Growth in the U.S. Antiviral …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on June 2, 2025 - 13:00 GMT

EcoFam Introduces Consumers to New Hydroxyapatite Toothpaste Tablets

Toothpaste Tablets Are a Sustainable, Fun, And Easy Way to Clean Your Teeth OREM, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Most Americans are used to brushing their teeth with a paste or gel dispensed from a plastic tube. Although …

Distribution channels: Beauty & Hair Care, Consumer Goods ...
Published on June 2, 2025 - 12:53 GMT

Deep Brain Stimulation Devices Market estimated to reach US$3,237.249 million by 2030 at a CAGR of 10.33%

The deep brain stimulation devices market is anticipated to grow at a CAGR of 10.33% from US$1,979.749 million in 2025 to US$3,237.249 million by 2030. NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- According to a new study …

Distribution channels: Healthcare & Pharmaceuticals Industry ...